These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 30575964

  • 1. HLA-selected platelets for platelet refractory patients with HLA antibodies: a single-center experience.
    Karlström C, Linjama T, Edgren G, Lauronen J, Wikman A, Höglund P.
    Transfusion; 2019 Mar; 59(3):945-952. PubMed ID: 30575964
    [Abstract] [Full Text] [Related]

  • 2. HLA-Mediated Platelet Refractoriness.
    Schmidt AE, Refaai MA, Coppage M.
    Am J Clin Pathol; 2019 Mar 01; 151(4):353-363. PubMed ID: 30285067
    [Abstract] [Full Text] [Related]

  • 3. An epitope-based approach of HLA-matched platelets for transfusion: a noninferiority crossover randomized trial.
    Marsh JC, Stanworth SJ, Pankhurst LA, Kallon D, Gilbertson AZ, Pigden C, Deary AJ, Mora AS, Brown J, Laing ES, Choo LL, Hodge R, Llewelyn CA, Harding K, Sage D, Mijovic A, Mufti GJ, Navarrete CV, Brown CJ.
    Blood; 2021 Jan 21; 137(3):310-322. PubMed ID: 33475737
    [Abstract] [Full Text] [Related]

  • 4. [Establish a Graded Method to Avoid HLA Class I Antibodies Corresponding Antigen and Combining HLAMatchmaker Application in Improving the CCI Value after Platelet Transfusion for Patients with IPTR].
    Gao SQ, Xu YP, Luo CR, Li DC, Pen L, Liu T, Zou QC.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Feb 21; 32(1):242-249. PubMed ID: 38387929
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Use of Human Leukocyte Antigen (HLA)-Incompatible Platelet Units in HLA Platelet-Refractory Patients With Limited Number of or Low-Level HLA Donor-Specific Antibodies Results in Permissive Transfusions.
    Sullivan JC, Peña JR.
    Arch Pathol Lab Med; 2022 Oct 01; 146(10):1243-1251. PubMed ID: 35171984
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Successful transfusion of platelets "mismatched" for HLA antigens to alloimmunized thrombocytopenic patients.
    Duquesnoy RJ, Filip DJ, Rodey GE, Rimm AA, Aster RH.
    Am J Hematol; 1977 Oct 01; 2(3):219-26. PubMed ID: 596366
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. HLAMatchmaker is effective for selecting appropriate platelet units for alloimmunised thrombocytopaenic patients who are refractory to random donor platelets.
    O'Rafferty C, Rooney G, Hagan R, Woolfson M, O'Donghaile D, Fitzgerald J.
    Transfus Med; 2017 Oct 01; 27 Suppl 5():369-374. PubMed ID: 28393455
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cross-match-compatible platelets improve corrected count increments in patients who are refractory to randomly selected platelets.
    Elhence P, Chaudhary RK, Nityanand S.
    Blood Transfus; 2014 Apr 01; 12(2):180-6. PubMed ID: 24333069
    [Abstract] [Full Text] [Related]

  • 15. Platelet transfusions: the problem of refractoriness.
    Murphy MF, Waters AH.
    Blood Rev; 1990 Mar 01; 4(1):16-24. PubMed ID: 2182145
    [Abstract] [Full Text] [Related]

  • 16. A prospective randomized trial of HLA-matched versus mismatched single-donor platelet transfusions in cancer patients.
    Messerschmidt GL, Makuch R, Appelbaum F, Ungerleider RS, Abrams R, O'Donnell J, Holohan TV, Fontana J, Wright D, Anagnou NP.
    Cancer; 1988 Aug 15; 62(4):795-801. PubMed ID: 3293762
    [Abstract] [Full Text] [Related]

  • 17. Selection of histocompatible apheresis platelet donors by cross-matching random donor platelet concentrates.
    O'Connell BA, Lee EJ, Rothko K, Hussein MA, Schiffer CA.
    Blood; 1992 Jan 15; 79(2):527-31. PubMed ID: 1730095
    [Abstract] [Full Text] [Related]

  • 18. A cost-effectiveness evaluation of platelet crossmatching and HLA matching in the management of alloimmunized thrombocytopenic patients.
    Freedman J, Gafni A, Garvey MB, Blanchette V.
    Transfusion; 1989 Jan 15; 29(3):201-7. PubMed ID: 2493693
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.